Danazol for uterine fibroids

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Ke, Lin Qiu ^b   Yang, Kun ^b   Li, Jing ^b   Li, Chun Mei ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL;

CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DEPRESSION; DIAGNOSTIC PROCEDURE; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; FATIGUE; HEADACHE; HUMAN; INSOMNIA; MEDICAL RESEARCH; NAUSEA; NERVOUSNESS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SIDE EFFECT; UTERUS MYOMA;

EID: 70049089853     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007692.pub2     Document Type: Review

References (33)

1. DeCherney AH, Maheux R, Polan ML. A medical treatment for myomata uteri. Fertility and Sterility 1983;39:429-430
2. Jie Zhang. Short-term effects of danazol for uterine fibroids. Medicine of Guangdong 1998;19(6):463-464
3. Peng Xue-feng, Wei Ai-min. Treatment of uterine leiomyoma with danazol or mifepristone. Practical Clinical Medicine 2002;3(5):105-106
4. Triolo O, De Vivo A, Benedetto V, Falcone S, Antico F. Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: A prospective, randomized evaluation. Fertility and Sterility 2006;85(4):1027-1031
5. Ueki M, Okamoto Y, Tsurunaga T, Seiki Y, Ueda M, Sugimoto O. Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin. Journal of Obstetrics and Gynecology 1995;21(1):1-7.
6. Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858]
7. Chavez NF, Stewart EA. Medical treatment of uterine fibroids. Clinical Obstetrics and Gynecology 2001;44:372-384
8. Donaldson VH. Danazol. The American Journal of Medicine 1989;87:49N-55N.
9. Donnez J, Squifflet J, Polet R, Nisolle M. Laparoscopic myolysis. Human Reproduction Update 2000;6:609-613
10. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate?. Human Reproduction 2002;17:1424-1430 (Pubitemid 34661784)
11. Goldberg J, Pereira L. Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy. Current Opinion in Obstetrics & Gynecology 2006;18:402-406 (Pubitemid 43964767)
12. Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J. Annual costs associated with diagnosis of uterine leiomyomata. Obstetrics and Gynecology 2006;108:930-937 (Pubitemid 44498255)
13. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0. The Cochrane Collaboration 2008.
14. Kogo H, Takasaki K, Yatabe Y, Nishikawa M, Takeo S, Tamura K. Inhibitory and stimulatory actions of danazol in rat ovarian and uterine tissues. European Journal of Pharmacology 1992;211:69-73.
15. Manyonda I, Sinthamoney E, Belli AM. Controversies and challenges in the modern management of uterine fibroids. BJOG: an international journal of obstetrics and gynaecology 2004;111:95-102. (Pubitemid 38186796)
16. Mauskopf J, Flynn M, Thieda P, Spalding J, Duchane J. The economic impact of uterine fibroids in the United States: a summary of published estimates. Journal of Women's Health 2005;14:692-703. (Pubitemid 41645631)
17. Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Current Opinion in Obstetrics & Gynecology 2004;16:239-243
18. Panidis D, Vavilis D, Rousso D, Stergiopoulos K, Kalogeropoulos A. Danazol influences gonadotropin secretion acting at the hypothalamic level. International Journal of Gynaecology and Obstetrics 1994;45:241-246 (Pubitemid 24182811)
19. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertility and Sterility 2007;87:725-736
20. Payson M, Leppert P, Segars J. Epidemiology of myomas. Obstetrics and Gynecology Clinics of North America 2006;33:1-11.
21. Pron G, Bennett J, Common A, Wall J, Asch M, Sniderman K. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertility and Sterility 2003;79:120-127
22. Schwartz SM. Epidemiology of uterine leiomyomata. Clinical Obstetrics and Gynecology 2001;44:316-326
23. Seifer DB, Freedman LN, Cavender JR, Baker RA. Insulin-dependent diabetes mellitus associated with danazol. American Journal of Obstetrics and Gynecology 1990;162:474-475 (Pubitemid 20068525)
24. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858] (Pubitemid 351805207)
25. Smart OC, Hindley JT, Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstetrics and Gynecology 2006;108:49-54. (Pubitemid 44336844)
26. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Human Reproduction Update 2007;13:465-476 (Pubitemid 47299852)
27. Spooner JB. Classification of side-effects to danazol therapy. The Journal of International Medical Research 1977;5:15-17
28. Stewart EA. Uterine fibroids. Lancet 2001;357:293-298
29. Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertility and Sterility 2006;85:22-29 (Pubitemid 43063413)
30. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstetrics and Gynecology 2004;104:393-406.
31. Worthington-Kirsch R, Spies JB, Myers ER, Mulgund J, Mauro M, Pron G. The Fibroid Registry for Outcomes Data (FIBROID) for uterine embolization: short-term outcomes. Obstetrics and Gynecology 2005;106:52-59 (Pubitemid 40898434)
32. Wu T, Chen X, Xie L. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858] (Pubitemid 351805367)
33. Zawar V, Sankalecha C. Facial hirsutism following danazol therapy. Cutis 2004;74:301-303 (Pubitemid 39612336)